The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes by time to adjuvant therapy in E3311, a phase II trial of transoral surgery (TOS) followed by pathology-based adjuvant treatment in HPV-associated (HPV+) oropharynx cancer (OPC): A trial of the ECOG-ACRIN Cancer Research Group.
 
Robert L. Ferris
Stock and Other Ownership Interests - Novasenta
Consulting or Advisory Role - Achilles Therapeutics; Adagene; Aduro Biotech; Bicara Therapeutics; Bristol-Myers Squibb; Cantenion; Coherus Biosciences; Eterna Therapeutics; Everest Clinical Research; F. Hoffmann LaRoche; Genocea Biosciences; Hookipa Pharma; Instil Bio; Kowa Research Institute; Lifescience Dynamics; Macrogenics; MeiraGTx; Merck; Mirati Therapeutics; Mirror Biologics; Nanobiotix; Novartis; Novasenta; Numab; OncoCyte; Pfizer; PPD; Rakuten Medical; Sanofi; Seagen; SIRPant Immunotherapeutics; VIR Biotechnology; Zymeworks; Zymeworks
Research Funding - AstraZeneca/MedImmune; Bristol-Myers Squibb; Merck; Novasenta; Tesaro
 
Yael Flamand
No Relationships to Disclose
 
Harry Quon
Employment - Johns Hopkins Hospital
Leadership - Pistevo Health
Stock and Other Ownership Interests - Oncospace; Pistevo Health
Honoraria - Sanofi/Regeneron
Consulting or Advisory Role - Pinnacle Biologics; Tactile Medical
Research Funding - Toshiba; Vibrent Health
Patents, Royalties, Other Intellectual Property - Filed under Hopkins, we have several patents related to mobile informatics solutions
Other Relationship - EPIC (I)
 
Gregory S. Weinstein
Patents, Royalties, Other Intellectual Property - Olympus
 
Ranee Mehra
Stock and Other Ownership Interests - GlaxoSmithKline (I)
Consulting or Advisory Role - Coherus Biosciences; Janssen Oncology
Research Funding - AstraZeneca; Merck
(OPTIONAL) Uncompensated Relationships - AstraZeneca
 
Joaquin J. Garcia
No Relationships to Disclose
 
Seungwon Kim
No Relationships to Disclose
 
Bert W. O'malley
No Relationships to Disclose
 
Enver Ozer
No Relationships to Disclose
 
Giovana R. Thomas
No Relationships to Disclose
 
Wayne Koch
No Relationships to Disclose
 
Michael Elliot Kupferman
Stock and Other Ownership Interests - Abbott Laboratories; Abbvie; Arlo; Intersect ENT
 
Richard Bryan Bell
Honoraria - Regeneron
Consulting or Advisory Role - Cortexyme; Macrogenics; Merck
Speakers' Bureau - Merck; Regeneron
Research Funding - Bristol-Myers Squibb/Celgene (Inst)
 
Mihir Patel
Consulting or Advisory Role - Intuitive Surgical
 
Miriam Lango
No Relationships to Disclose
 
Barbara Burtness
Consulting or Advisory Role - Abbvie; ALX Oncology; Arvinas; Coherus Biosciences; CUE Biopharma; Genentech/Roche; IO Biotech; Kura Oncology; Macrogenics; Merck; Merck KGaA; Vaccinex
Speakers' Bureau - Clinical Education Alliance; Oncology Education
Research Funding - CUE Biopharma (Inst); Exelixis (Inst); Merck; Merck (Inst)